Related Experiment Videos
Beta-blockers increase bone mineral density
Sonay Turker1, Vasfi Karatosun, Izge Gunal
1Department of Cardiology, Dokuz Eylul University Hospital, Izmir, Turkey.
Clinical Orthopaedics and Related Research
|February 8, 2006
Summary
Beta-blocker use in the elderly was associated with increased bone mineral density. This prospective study found higher bone density in beta-blocker users compared to non-users, suggesting a potential benefit for bone health.
Area of Science:
- Gerontology
- Pharmacology
- Orthopedics
Background:
- Animal studies suggest beta-blockers influence bone metabolism.
- Human data on beta-blockers and bone mineral density are limited and conflicting.
Purpose of the Study:
- To investigate the effect of beta-blockers on bone mineral density in an elderly population.
- To compare bone mineral density between elderly beta-blocker users and non-users.
Main Methods:
- Prospective case-control study.
- Involved 50 beta-blocker users and 100 non-users (no anti-resorptive medication).
- Measured bone mineral density at various skeletal sites.
Main Results:
- Beta-blocker users demonstrated significantly greater bone mineral density at all measured sites.
- Specific bone mineral density values for total hip and spine were provided for both groups.
- The association suggests a positive impact of beta-blockers on bone density.
Conclusions:
- Beta-blocker use is linked to increased bone mineral density in the elderly.
- Findings suggest a potential role for beta-blockers in improving bone health in older adults.